clinical trial · NCT07215585
AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL
AstraZeneca·phase3·recruiting·n = 420
Large B-cell LymphomaAZD0486R-mini-CHOP
brief summary
The purpose of this study is to measure the efficacy and safety of R-mini-CHOP × 2 followed by AZD0486 compared with R-mini-CHOP × 6 in elderly or unfit participants newly diagnosed with LBCL.
started
Nov 11, 2025
primary completion
Jun 10, 2030
completion
Jul 28, 2033
last updated
Apr 21, 2026
official title
A Phase III, Multicentre, Open-Label, Randomised Study Evaluating the Efficacy and Safety of R-mini-CHOP x2 Followed by AZD0486 Versus R-mini-CHOP x6 in Elderly or Unfit Participants With Newly Diagnosed Large B-cell Lymphoma (SOUNDTRACK-D2)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol